University of Saskatchewan

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1907-01-01

Employees: 5K

Market Cap: -

Website: http://www.usask.ca

Clinical Trials

Treatment of Ligneous Conjunctivitis in Children With Plasminogen Deficiency

Not Applicable

Recruiting

Conditions: Plasminogen Deficiency

Interventions: Drug: Aliquoted allogeneic donor plasma in patient's conjunctiva

First Posted Date: 2022-06-03

Last Posted Date: 2023-12-15

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 1

Registration Number: NCT05404932

Locations: 🇨🇦
University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Shoulder Rehabilitation Using a Mobile App Following Breast Reconstruction

Not Applicable

Completed

Conditions: Shoulder Dysfunction
Breast Reconstruction

Interventions: Other: Education via a Mobile App
Other: Education and Exercise via a Mobile App

First Posted Date: 2022-05-24

Last Posted Date: 2023-12-05

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 22

Registration Number: NCT05388240

Locations: 🇨🇦
University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Pole Walking Intervention in Retirement Communities

Conditions: Fall Injury
Osteoporotic Fractures

Interventions: Other: Pole Walking

First Posted Date: 2022-05-24

Last Posted Date: 2022-08-17

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 50

Registration Number: NCT05388227

Locations: 🇨🇦
Saija Kontulainen, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Milk Versus a Pea-based Beverage for Bone and Muscle Health in Young Athletes

Not Applicable

Completed

Conditions: Muscle Atrophy

Interventions: Dietary Supplement: Nutritional supplementation during a 6 month resistance training program

First Posted Date: 2022-05-19

Last Posted Date: 2024-05-29

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 112

Registration Number: NCT05382026

Locations: 🇨🇦
University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Passive Leg Raise for Pediatric Peripheral IV Placement

Not Applicable

Completed

Conditions: Anesthesia
Children, Only

Interventions: Procedure: Passive Leg Raise

First Posted Date: 2022-03-28

Last Posted Date: 2022-11-03

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 234

Registration Number: NCT05298137

Locations: 🇨🇦
Jim Pattison Children's Hospital, Saskatoon, Saskatchewan, Canada

Neuromodulation in MS Using Translingual Stimulation

Not Applicable

Conditions: Multiple Sclerosis

Interventions: Combination Product: PT plus translingual stimulation control device
Combination Product: PT plus translingual stimulation device

First Posted Date: 2022-03-11

Last Posted Date: 2022-03-11

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 52

Registration Number: NCT05275049

Locations: 🇨🇦
University of Saskatchewan, Saskatoon, Saskatchewan, Canada
🇨🇦
Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada

Stretching vs Walking for Lowering Blood Pressure

Not Applicable

Recruiting

Conditions: Hypertension

Interventions: Other: Walking exercise
Other: Stretching exercise

First Posted Date: 2022-02-23

Last Posted Date: 2024-05-29

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 96

Registration Number: NCT05252208

Locations: 🇨🇦
University of Saskatchewan, Saskatoon, Saskatchewan, Canada

The Effects of Targeted Phantom Motor Execution on Phantom Limb Control

Not Applicable

Completed

Conditions: Amputation Stump
Motor Activity
Phantom Limb
Amputation

Interventions: Other: Targeted phantom limb motor execution (exercise)

First Posted Date: 2022-02-21

Last Posted Date: 2023-12-08

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 30

Registration Number: NCT05247827

Locations: 🇨🇦
Winnipeg Prosthetics and Orthotics (WinPO) Clinic, Winnipeg, Manitoba, Canada

Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.

Phase 1

Completed

Conditions: Double Vaccinated for COVID-19 (For Phase 1 of the Study)
Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)

Interventions: Biological: COVAC-2
Biological: Saline Placebo

First Posted Date: 2022-02-07

Last Posted Date: 2024-05-03

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 60

Registration Number: NCT05226702

Locations: 🇨🇦
Manna Research (Burlington North), Burlington, Ontario, Canada
🇨🇦
Manna Research, Toronto, Ontario, Canada
🇨🇦
Canadian Center for Vaccinology, Saskatoon, Saskatchewan, Canada

A Clinical Trial of COVAC-2 in Adults

Phase 2

Completed

Conditions: Severe Acute Respiratory Syndrome Coronavirus 2

Interventions: Biological: COVAC-2
Biological: Saline Placebo

First Posted Date: 2022-01-26

Last Posted Date: 2024-05-02

Lead Sponsor: University of Saskatchewan

Target Recruit Count: 150

Registration Number: NCT05209009

Locations: 🇺🇬
Epicentre, Mbarara Research Centre, Mbarara, Uganda
🇺🇬
Uganda Virus Research Institute, Entebbe, Uganda

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy